Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?
Gisèle Pickering,1 Sylvia Engelen,2 Maria Stupar,2 Hervé Ganry,3 Mariëlle Eerdekens2 1Faculty of Medicine Inserm 1107, Clinical Pharmacology Centre, CPC/CIC Inserm 1405 University Hospital, Clermont-Ferrand, France; 2Grünenthal GmbH, Aachen, Germany; 3Hergan Consulting 4U, Amiens, 80000, FranceCorre...
Κύριοι συγγραφείς: | Pickering G, Engelen S, Stupar M, Ganry H, Eerdekens M |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Dove Medical Press
2024-03-01
|
Σειρά: | Journal of Pain Research |
Θέματα: | |
Διαθέσιμο Online: | https://www.dovepress.com/is-the-capsaicin-179-mg-8-ww-cutaneous-patch-an-appropriate-treatment--peer-reviewed-fulltext-article-JPR |
Παρόμοια τεκμήρια
-
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
ανά: Huygen F, κ.ά.
Έκδοση: (2020-10-01) -
Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
ανά: Colette Mankowski, κ.ά.
Έκδοση: (2017-04-01) -
Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
ανά: Eulalie Laude-Pagniez, MD, κ.ά.
Έκδοση: (2022-12-01) -
Capsaicin in the Treatment of Refractory Neuropathic Pain after Mastectomy Surgery: A Case Report
ανά: Lilit Flöther, κ.ά.
Έκδοση: (2020-08-01) -
Characteristics of Analgesic Patch Formulations
ανά: Nalamachu S, κ.ά.
Έκδοση: (2020-09-01)